“GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS: Gilteritinib (XOSPATA ®) in Turkey” (2023) Mediterranean Journal of Hematology and Infectious Diseases, 15(1), p. e2023031. doi:10.4084/MJHID.2023.031.